Related Experiment Video
Updated: Jun 11, 2025

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Clustering Based on Laboratory Data in Patients With Heart Failure Admitted to the Intensive Care Unit
Sepehr Nemati1, Babak Mohammadi2, Zahra Hooshanginezhad3
1Department of Cardiology, BooAli Hospital, Azad University of Medical Sciences, Tehran, Iran.
Insights
Routine laboratory biomarkers identified two distinct heart failure patient phenotypes in the ICU. These phenotypes significantly impact mortality risk and can be distinguished by blood cell counts and electrolyte levels.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Biomarker Discovery
Background:
- Heart failure (HF) presents a substantial healthcare burden.
- Identifying patient subgroups in intensive care units (ICUs) is crucial for tailored treatment.
- Routinely measured laboratory biomarkers can aid in subgroup identification.
Purpose of the Study:
- To identify distinct patient subgroups among those with heart failure admitted to the ICU.
- To characterize these subgroups using laboratory biomarkers.
- To assess the prognostic significance of identified subgroups.
Main Methods:
- Analysis of a large dataset (N=1176) of ICU-admitted heart failure patients.
- Clustering of patients based on laboratory biomarkers to identify phenotypes.
- Cluster profiling using binary logistic models for characterization.
Main Results:
- Two distinct patient clusters (N=679 and 497) were identified.
- Significant differences in mortality rates (7.4% vs. 21.9%) between clusters.
- Cluster 2 patients were older and had higher rates of chronic kidney disease; significant predictors included leukocyte count, MCV, RBC distribution width, HcT, lactic acid, BUN, potassium, magnesium, and sodium.
Conclusions:
- Two heart failure phenotypes were identified in ICU patients using laboratory data.
- These phenotypes hold prognostic importance regarding mortality.
- Differentiation is achievable through blood cell counts, kidney function, and serum electrolytes.
Background:
Heart failure (HF) is a common condition that imposes a significant burden on healthcare systems. We aimed to identify subgroups of patients with heart failure admitted to the ICU using routinely measured laboratory biomarkers.
Methods:
A large dataset (N = 1176) of patients with heart failure admitted to the ICU at the Beth Israel Deaconess Medical Center in Boston, USA, between June 1, 2001, and October 31, 2012, was analyzed. We clustered patients to identify laboratory phenotypes. Cluster profiling was then performed to characterize each cluster, using a binary logistic model.
Results:
Two distinct clusters of patients were identified (N = 679 and 497). There was a significant difference in the mortality rate between Clusters 1 and 2 (50 [7.4%] vs. 109 [21.9%], respectively, p < 0.001). Patients in the Cluster 2 were significantly older (mean [SD] age = 72.35 [14.40] and 76.37 [11.61] years, p < 0.001) with a higher percentage of chronic kidney disease (167 [24.6%] vs. 262 [52.7%], respectively, p < 0.001). The logistic model was significant (Log-likelihood ratio p < 0.001, pseudo R2 = 0.746) with an area under the curve of 0.905. The odds ratio for leucocyte count, mean corpuscular volume (MCV), red blood cell (RBC) distribution width, hematocrit (HcT), lactic acid, blood urea nitrogen (BUN), serum potassium, magnesium, and sodium were significant (all p < 0.05).
Conclusion:
Laboratory data revealed two phenotypes of ICU-admitted patients with heart failure. The two phenotypes are of prognostic importance in terms of mortality rate. They can be differentiated using blood cell count, kidney function status, and serum electrolyte concentrations.
More Related Videos
Related Concept Videos
Heart Failure V: Nursing Interventions
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management
Acute Coronary Syndrome III: Diagnostic studies
Heart Failure VI: Adjunct Therapies

